ENInstrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2025 Earnings Call Transcript
Vir Biotechnology (VIR) Unveils Promising Hepatitis B Treatment Data | VIR Stock News
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study | Morningstar
Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
Q1 2025 Vir Biotechnology Inc Earnings Call Transcript
Barclays PLC Has $1.62 Million Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)
1,084,539 Shares in Vir Biotechnology, Inc. (NASDAQ:VIR) Bought by Baker BROS. Advisors LP
Quarry LP Sells 11,000 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
BlackRock, Inc. Reduces Stake in Vir Biotechnology Inc.
VIR Q1 2025 Earnings Report on 5/1/2025
Syon Capital LLC Makes New $77,000 Investment in Vir Biotechnology, Inc. (NASDAQ:VIR)
Vir Biotechnology (VIR) to Release Earnings on Thursday
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Analysts
Vir Biotechnology (NASDAQ:VIR) Shares Up 5.5% - Here's What Happened
Vir Biotechnology, Inc. (NASDAQ:VIR) Short Interest Up 28.3% in March
Walleye Capital LLC Increases Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR)
Renaissance Technologies LLC Buys 55,300 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
New Mpro inhibitors revealed in Vir Biotechnology patent | BioWorld
